MENU
SYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Spyre Therapeutics (SYRE) Ownership - Who owns Spyre Therapeutics?
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
849.89M
P/E Ratio
1.72
Total Cash
564.82M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
3.96
Dividend Yield
N/A
Total Cash/Share
9.37
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SYRE
Capitalization
850M
P/E Ratio
1.72
Risk (Beta)
3.96
Dividend Yield
N/A
Total Cash
565M
Total Cash/Share
9.37
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
327M
P/B Ratio
2.75
Cash Flow
N/A
Earnings
-3.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
8.06
Current Revenue Per Employee
49142.86
Dividends Per Share - Security
N/A
EBITDA
-214.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.46
Shares Held By Institutions
1.81B
Shares Outstanding - Current
60.3M
Total Liabilities
87.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
-35.868
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com